Vol.
174,
No.
January
2,
BIOCHEMICAL
1991
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
Pages
31, 1991
625-630
SALIVARY HISTATIN AS AN INHIBITOR OF A PROTEASE PRODUCED BY THE ORAL BACTERIUM BACTEROlDES GINGlVALIS Makoto
“Oral
Nishikatal, Takashi KanehiraZ, Hourei Oh”, Hiroshi Mariko Tazaki”, and Yoshinori Kuboki”
‘(:entral Research Division and Departments of 2 Preventive Biochemistry, School of Dt>ntistry, Hokkaido University,
Received
December
12,
Tani2,
Dentistry Sapporo
and .Japan
060,
1990
examined the effect of histatin 5 from human parotid saliva on various Histatin 5 strongly inhibited a trypsin-like protease produced by Hacteroides gingivalis with an I(:50 value of 55 nM. Clostripain was also inhibited (lC50=800 nM). Activities of other proteases were not affected significantly. Because B. gingivalis is a suspected periodontal pathogen and its proteolytic enzymes have been considered to be associated with periodontal tissue destruction, it is suggested that salivary histatins play a role as a preventive against periodontal disease. 0 1991 Rcademlc fre5.5, Inc. We
proteases.
Histatins unusually acid
arc
high
residues
a
family
content in
of
salivary
of hjstidinc
histatin
characterized
polypeptides
residue,
which
comprises
saliva
activities
( 1).
and
a histamine
ical
role
In this examined strong suspected
Although
against
study, the
histatins
releasing cavity
to obtain effect
inhibitor
of
Abbreviations: Bz, thiobenzyl ester: aminoethanesulfonic propanesulfonate.
antibacterial
mutans
and
29% of the
from
remains
to be elucidated.
further histatin
a pathogen
rat
information 5 on from of adult
various
of
Lho
(2)
and
Candida
activity
of a protease
of being
one
have
Streptococcus
in the oral
their amino
5 (Asp-Ser-flis-Ala-Lys-Arg-His-His-Gly-Tyr-l,ys-Arg-
Lrs-P~~e-His-Glu-l,ys-His-His-His-Ser-t~is-Ar~-Gl~-‘~yr), in
hy
mast
ceils
on the
(41,
periodontal
Eingivalis, disease
(3)
respectively, their
function and
histatins
antifungal
albkans,
proteases
Bacteroides
ma.jor
true
of
histatins,
found an
biolog-
oral
it
to
we he
bacterium
(5).
benzoyl; Z, henzyloxycarhonyl; pNA, pnitroanilide; OEt, ethyl ester: TES, N-trisf hydroxymethyl)methyl-Zacid: CHAPS, 3-l (3-cholamidopropyl)dimethyiammonio]-l-
SBzl,
a
Vol.
174,
No.
2, 1991
BIOCHEMICAL
MATERIALS
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
AND METHODS
Materials: The following enzymes were obtained as indicated: bovine chymotrypsin (type Il), porcine elastase (type I), human thrombin (3313 r&l units/mg protein), papain (twice crystallized) and clostripain (132 units/mg protein) (Sigma, St. Louis); Flavobacterium meningosepticum prolyl endopeptidase (Seikagaku Kogyo, Tokyo); Clostridium histolyticum collagenase (CLSPA grade) (Worthington, Freehold); bovine trypsin (Boehringer, Mannheim). Preparation of Histatin 5: reported elsewhere. Briefly, separated by hydroxyapatite urea. Fractions containing a into individual components by the main peak was found to this study. Its concentration
The detailed purification procedure will be pooled parotid saliva from healthy adults was column chromatography in the presence of 6 M mixture of his&&ins were pooled and separated reversed-phase HPLC. The component eluted as be histatin 5 by sequence analysis and used in was determined by amino acid analysis.
Purification of B. gingivalis Trypsin-Like Protease: The whole envelope fraction of B. gingivalis 381 prepared as described previously (6) was homogenized with a Teflon homogenizer in 20 mM phosphate buffer (pH 7.3) containing 1% CHAPS, 25 mM 2-mercaptoethanol and 5 mM methylguanidine. Methylguanidine was added to prevent autodigestion of the protease. The homogenate was centrifuged (110,000 x g, 1 h) and the supernatant was subjected to gel filtration (all chromatography done at 4°C) on a column of Bio-Gel A-0.5m (Bio-Rad) equilibrated with the same buffer as above except that CHAPS and methylguanidine concentrations were 0.5% and 1 mM, respectively. Elution with this buffer was monitored by measuring the enzymatic activity toward 0.2 mM BzArg-pNA at pH 8.5. Pooled active fractions were then applied to a column of DE-52 (Whatman) equilibrated as above. Active fractions eluted by NaCl linear gradient elution were pooled, diluted J-fold and subjected to the same DE-52 column chromatography. The overall yield of the activity was 58%. SDSpolyacrylamide gel electrophoresis of the fraction with the highest activity gave a single but broad protein band around 85 kDa under reducing conditions. This fraction was used in this study after removal of methylguanidine by dialysis. The purified protease, like trypsin, hydrolyzed only those synthetic substrates containing arginine or lysine. The arginine-containing substrates were hydrolyzed more rapidly than the corresponding lysine analogs. The Km value for the hydrolysis of Bz-Arg-pNA by this enzyme was determined to be 1.9 ,Y M at pH 8.5 and 25°C. Other enzymatic properties were essentially the same as those reported for the partially purified protease from B. gingivaljs (6). Since our purified protease resembles trypsin in cleavage specificity, we will refer to this protease as ‘trypsin-like protease’ in this report. Assay of Protease: Protease activity was measured with specific synthetic substrates (6-14). Hydrolysis of substrates was started by addition of 5 ,U 1 of an enzyme solution to 0.5 ml of thermostated (25 “C) 50 mM TES-NaOH (pH 7.5) which contained a substrate and, if necessary, histatin 5. In addition, the assay mixture contained 10 mM CaClz (collagenase assay), 1 mM dithiothreito1 (papain and clostripain assays), 5-5’-dithiobis(2-nitrobenzoic acid) (trypsin and thrombin assays) and 50 mM 2-mercaptoethanol (B. gingivalis trypsin-like protease assay). Papain and clostripain had been activated by 10 mM dithiothreitol before added to the substrate solution. Hydrolysis was then followed at 25°C by continuous monitoring of the change of absorbance at 410 nm (p-nitroanilides), 412 nm (Z-Lys-SBzl), 324 nm (furanacryloyl-Leu-Gly-Pro-Ala) and 254 nm (Be-Tyr-OEt). Enzyme concentration was estimated by normality titration (trypsin and CL-chymotrypsin) (15, 16), spectrophotometrically (elastase and papain) or on the weight basis assuming that the enzymes are pure (thrombin, prolyl endopeptidase, collagenase and clostripain). 626
Vol.
174,
No.
BIOCHEMICAL
2, 1991
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
RESULTS Effect
of histatin
5 on
initial
rates
of substrate
(Fig.
1).
The
B.
Obviously
substrate
from
Fig.
10 ,u M histatin plete.
5.
almost
protease 1, the
B.
was
investigated
presence
about
Km for
0.1
protease
gingivalis
of clostripain
was
inhibited.
were
was also Other
comparing
by
absence
and
employed
and
moderately
was
of histatin
about the
0.5
other
inhibited
5
Km
for
proteases.
completely
remarkable
but
protease
activities
by
not
comwere
unaffected. The
inhibition
of the
as
a function
investigated 1 uMM, histatin The
al.
in the
concentrations
Inhibition
Collagenase
proteases
hydrolysis
trypsin-like
gingivalis
various
5 could
concentration
B.
of inhibit
of
protease
gingivalis
histatin
histatin the
B.
and
clostripain
5 concentration
(Fig.
further Even
2).
protease
completely
the
protease
activity
02
0
gingivdis
5 at which
was
at
(curve is
half
of
Trypsln Thrombln Chymotrypsi
n
Elastase Proly1 endopept
idase
Collagenase Papa
in
Clostripain B.glngivalis protease
01
0
ACTIVITY50
Fig.
1. Effect of histatin presence of 10 WM histatin absence of histatin 5. as follows: trypsin (0.26 (4fiM); o-chymotrypsin succinyl-Ala-Ala-Ala-pNA pNA (0.1 mM); collagenase papain (69 nM)/Bz-Arg-pNA B. gingivalis trypsin-like (1 PM). Fig. 2. Inhibition of clostripain (c) by histatin was assumed to be 100. (b), and 80 ,uM (c).
100
0.01
HISTATIN 01
15 (PM)
Protease activities in the 5 on various proteases. 5 are shown as percentages of the activity in the Protease/substrate pairs and their concentrations are nM)/Z-Lys-SBzl (5 ,uM); thrombin (3.0 nM)/Z-Lys-SBzl (3.2 nM)/Bz-Tyr-OEt (0.26 mM); elastase (0.17 ,uM)/ (0.1 mM); prolyl endopeptidase (9.2 nM)/ Z-Gly-Pro(0.1 fi M)/2-furanacryloyl-Leu-Gly-Pro-Ala (50 ,U M); (0.3 mM); clostripain (8.4 nM)/Bz-Arg-pNA (80 KM); protease (concentration not determined)/ Bz-Arg-pNA gingivalis Protease The concentration
B.
5.
trypsin-like protease (a and b) and activity in the absence of histatin 5 of Bz-Arg-pNA is 1 UM (a), 10 tiM
627
10
Vol.
174,
the
No.
2, 1991
uninhibited
ICso
value
Values
value for
the
of 55 nM
(0.53
Km) and
clostripain
(lC50) B.
(5.3
from
protease 200
Km)
estimated
BIOPHYSICAL
estimated
a) and
10 ,uM
AND
was
gingivalis
(curve
was
(curve
BIOCHEMICAL
to
(curve
Bz-Arg-pNA, be
800
the
varied
nM
RESEARCH
curves
with b)
in
with
were
80
Fig.
substrate
The
with
The
,uM
2.
concentration.
obtained
respectively.
nM
COMMUNICATIONS
(0.1
IC5o Km)
1 ,uM
value
for
Bz-Arg-pNA
c).
DlSCUSSlON Although 4),
little
In
the
several
is
known
present
study,
we
examined
found
that
histatin
tease
with
an
u M, which bition the
most The
to
be
tion.
type
not
activity of inhibition
according and
the
taken values
is
protease
for
properties. cleavage
example, specificity
arginine
over
on
the
molecular
proteases,
and
trypsin-like
gingivalis
IC5o
to experimental
pro-
values
concentrations
in this
(2-
specifically.
various
Lower
2).
observed
B.
would well
study
be
below
difficulties.
equation
The
seems
Ki
on
to
1
inhi-
be
far
so
histatin were
histatin
histatin
concentra-
(Ki)
the
lC50
V are
the
using
where
v and
hydrolysis,
respectively,
5 concentration. calculated
to
5 appears
substrate
constant
substrate
200 nM,
because
lysine
of
values
similar
dependent
of inhibition
I is
both
was
by
~=VS/lStKm(ltl/Ki)l,
rates and
protease
gingivalis
value
values
that
clostripain, For
lC50
of 55 nM and
noteworthy
and
for
Km.
histatins
at substrate
owing
of the
maximum
concentration
IC50
It
to the
B.
reported
of histatin.
to determine
,YM was
done
been interact
5 and
of
(Fig.
done
protease
We tried
Bz-Arg-pNA
erence
was
of
histatin
55 nM
have
histatins
functions
inhibitor
was
because
observed
strict
of
competitive
values
using
value
gingivalis
pot,ent
molecule(s)
between
experiment
B.
of histatins
to understand
5 is a strong
actually
of the
what
interaction
IC50
if the
activities
as to with
basis,
obtained
biological
be
36
S is
A value
of
1.9
nM
32
nM
and
respectively. 5
inhibits
these
two
enzymes
are
to that (6, 17).
628
enzymes
8.
share
sulfhydryl-dependent
of trypsin
trypsin-like
gingivalis
but
show
similar
enzymatic and
a marked
have pref-
a
Vol.
174,
No.
The
we infer the
protease histatin
BIOCHEMICAL
protease-inhibitory
However, inhibits
2, 1991
B.
from
site
5 essential
consideration The with
mechanism the
forming for
the
is
can
be
histatins
for
the
complete
assuming
that
all
activities with
produced
preventive
evaluate
histatin
trypsin-like
periodontal
histatin
said
tissue
against content the
by
significance
human
saliva
have
the
disease. the
of hi&&ins
191,
A survey
degree
of periodontal
in this
al.,
the
into
greatly
unpublished). amount
of
protease
major
considered
on
in
activity.
are
histatins
to the
residue
varies
trypsin-like
same inhibitory
been
5
taking
sufficient
gingivalis
have
(18,
et
contains
histatin
enzymes. saliva
M (Oh
activities
and
destruction
10e5
B.
collagenolytic
gingivalis
and
in human
acid
lysine
of both
present.
binding
amino or
at
that
by
The
residue
of
study
arginine
of
clear
clostripain
of histatins
inhibition
periodontal in saliva
acid
COMMUNICATIONS
not
this
complex.
an order
species
B.
in
is probably
that
and
5 is
probably
amino
roughly
it
Since
for
RESEARCH
histatin
obtained
and
of a mixture
but
of
data
binding
preference
individuals
BIOPHYSICAL
a noncovalent
the
concentration
Therefore,
limited
protease
gingivalis
active
AND
may the
protease
to be associated play
a role
correlation
disease
as a
between
is required
to
disease.
ACKNOWLEDGMENTS We thank Prof. F. Yoshimura of Aichi-Gakuin University, Nagoya, for providing us with cells of B. gingivalis 381. We also thank Drs. S. Abe and R. Muramatsu of Nippon Mining Co., Tokyo, for excellent amino acid sequence analysis of histatin 5.
REFERENCES 1.
2. 3. 4.
5. 6. 7.
8. 9.
Oppenheim, F.G., Xu, T., McMillian, F.M., Levitz, S.M., Diamond, R.D., Offner, G.D., and Troxler, R.F. (1988) J. Biol. Chem. 263, 7472-7477. McKay, B.J., Denepitiya, L., Iacono, V.J., Krost, S.B., and Pollock, J..J. (1984) Infect. Immun. 44, 695-701. Pollock, J.J., Denepitiya, L., McKay, B.J., and lacono, V.J. (1984) Infect. Immun. 44, 702-707. Su$iyama, K., Suzuki, Y., and Furuta, H. (1985) Life Sci. 37, 475-480. Slots, J., Bragd, L., Wikstrom, M., and Dahlen, G. (1986) J. Clin. Periodontol. 13, 570-577. Yoshimura, F., Nishikata, M., Suzuki, ‘I?., Hoover, C.l., and Newbrun, E. (1984) Arch. Oral Biol. 29, 559-564. Green, G.D.J., and Shaw, E. (1978) Anal. Biochem. 93, 223-226. Hummel, B.C.W. (1959) Can. J. Biochem. Physiol. 37, 1393-1399. Folk, J.E., and Schirmer, E.W. (1965) .J. Biol. Chem. 240, 181-192.
629
Vol.
10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
174, No. 2, 1991
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
Bieth, J., Sppiess, B., and Wermuth, C.G. (1974) B&hem. Med. 11, 350357 Nishikata, M., Yokosawa, H., and Ishii, S. (1986) Chem. Pharm. Bull. 34, 2931-2936. van Wart, H.E., and Steinbrink, D.R. (1981) Anal. Biochem. 113, 356-365 Mole, J.E., and Horton, H.R. (1973) Biochemistry 12, 816-822. Cole, P.W., Murakami, K., and Inagami, T. (1971) Biochemistry 10, 42464252. Chase, T., Jr., and Shaw. E. (1969) Biochemistry 8, 2212-2224. Gertler, A., Walsh, K.A., and Neurath, H. (1974) Biochemistry 13, 13021310. Mitchell, W.M., and Harrington, W.F.(1968) J. Biol. Chem. 243, 4683-4692. Slots, J., and Genco, R.J. (1984) J. Dent. Res. 63, 412-421. Mayrand, D., and Holt, S.C. (1988) Microbial. Rev. 52, 134-152.
630